| 1 |
Ma S, Zhao H, Wang F, Peng L, Zhang H, Wang Z, Jiang F, Zhang D, Yin M, Li S, Huang J, Liu Z, Tao S. Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue. Aging (Albany NY) 2023;15:1628-51. [PMID: 36917093 DOI: 10.18632/aging.204580] [Reference Citation Analysis]
|
| 2 |
Shi Z, Li G, Zhai Y, Pan C, Wang D, Yu M, Liu C, Zhang W, Yu X. EGFRvIII Promotes the Proneural–Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis. Genes 2023;14:651. [DOI: 10.3390/genes14030651] [Reference Citation Analysis]
|
| 3 |
Pasieka R, Zasoński G, Raczyńska KD. Role of Long Intergenic Noncoding RNAs in Cancers with an Overview of MicroRNA Binding. Mol Diagn Ther 2023;27:29-47. [PMID: 36287372 DOI: 10.1007/s40291-022-00619-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 4 |
Goenka A, Tiek DM, Song X, Iglesia RP, Lu M, Hu B, Cheng S. The Role of Non-Coding RNAs in Glioma. Biomedicines 2022;10:2031. [DOI: 10.3390/biomedicines10082031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Yuan E, Liu K, Lee J, Tsung K, Chow F, Attenello FJ. Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes. Neurooncol Adv 2022;4:vdac119. [PMID: 36105389 DOI: 10.1093/noajnl/vdac119] [Reference Citation Analysis]
|
| 6 |
Gao Z, Xu J, Fan Y, Qi Y, Wang S, Zhao S, Guo X, Xue H, Deng L, Zhao R, Sun C, Zhang P, Li G. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition. J Exp Clin Cancer Res 2022;41:223. [PMID: 35836243 DOI: 10.1186/s13046-022-02431-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Chen X, Guo J, Zhou F, Ren W, Huang X, Pu J, Niu X, Jiang X. Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma. Front Oncol 2022;12:905871. [PMID: 35651789 DOI: 10.3389/fonc.2022.905871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Wang Y, Li Y, Sun Q, Yuan F, Xu Y, Tong S, Li Y, Yi S, Yan T, Chen Q, Liu B. BCAS3 accelerates glioblastoma tumorigenesis by restraining the P53/GADD45α signaling pathway. Exp Cell Res 2022;:113231. [PMID: 35659972 DOI: 10.1016/j.yexcr.2022.113231] [Reference Citation Analysis]
|
| 9 |
Wu YZ, Su YH, Kuo CY. Stressing the Regulatory Role of Long Non-Coding RNA in the Cellular Stress Response during Cancer Progression and Therapy. Biomedicines 2022;10:1212. [PMID: 35625948 DOI: 10.3390/biomedicines10051212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Ahmadpour S, Taghavi T, Sheida A, Tamehri Zadeh SS, Hamblin MR, Mirzaei H. Effects of microRNAs and long non-coding RNAs on chemotherapy response in glioma. Epigenomics 2022. [PMID: 35473299 DOI: 10.2217/epi-2021-0439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Liu K, Chen H, Wang Y, Jiang L, Li Y. Evolving Insights Into the Biological Function and Clinical Significance of Long Noncoding RNA in Glioblastoma. Front Cell Dev Biol 2022;10:846864. [DOI: 10.3389/fcell.2022.846864] [Reference Citation Analysis]
|
| 12 |
Zhang J, Guan M, Zhou X, Berry K, He X, Lu QR. Long Noncoding RNAs in CNS Myelination and Disease. Neuroscientist 2022;:10738584221083919. [PMID: 35373640 DOI: 10.1177/10738584221083919] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Mousavi SM, Derakhshan M, Baharloii F, Dashti F, Mirazimi SMA, Mahjoubin-Tehran M, Hosseindoost S, Goleij P, Rahimian N, Hamblin MR, Mirzaei H. Non-coding RNAs and glioblastoma: Insight into their roles in metastasis. Mol Ther Oncolytics 2022;24:262-87. [PMID: 35071748 DOI: 10.1016/j.omto.2021.12.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 14 |
Cardon T, Fournier I, Salzet M. Unveiling a Ghost Proteome in the Glioblastoma Non-Coding RNAs. Front Cell Dev Biol 2021;9:703583. [PMID: 35004666 DOI: 10.3389/fcell.2021.703583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Wang Z, Yang X, Gui S, Yang F, Cao Z, Cheng R, Xia X, Li C. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Front Pharmacol 2021;12:779606. [PMID: 34899344 DOI: 10.3389/fphar.2021.779606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Zhou Q, Liu L, Zhou J, Chen Y, Xie D, Yao Y, Cui D. Novel Insights Into MALAT1 Function as a MicroRNA Sponge in NSCLC. Front Oncol 2021;11:758653. [PMID: 34778078 DOI: 10.3389/fonc.2021.758653] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Liguori G, Cerrone M, De Chiara A, Tafuto S, Tracey de Bellis M, Botti G, Di Bonito M, Cantile M. The Role of lncRNAs in Rare Tumors with a Focus on HOX Transcript Antisense RNA (HOTAIR). Int J Mol Sci 2021;22:10160. [PMID: 34576322 DOI: 10.3390/ijms221810160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Nie J, Feng Y, Wang H, Lian XY, Li YF. Long Non-Coding RNA SNHG6 Supports Glioma Progression Through Upregulation of Notch1, Sox2, and EMT. Front Cell Dev Biol 2021;9:707906. [PMID: 34485294 DOI: 10.3389/fcell.2021.707906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Qian Z, Chen L, Wang X, Kan Y, Wang Y, Yu Y, Wang X, Zhao Z, Yang H, Ge P, Ding T, Zhai Q, Zhao H. Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma. Clin Exp Med 2021. [PMID: 34427833 DOI: 10.1007/s10238-021-00748-2] [Reference Citation Analysis]
|
| 20 |
Wu Q, Berglund AE, Etame AB. The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma. Int J Mol Sci 2021;22:8324. [PMID: 34361090 DOI: 10.3390/ijms22158324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 21 |
Zheng H, Chen C, Luo Y, Yu M, He W, An M, Gao B, Kong Y, Ya Y, Lin Y, Li Y, Xie K, Huang J, Lin T. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer. Clin Transl Med 2021;11:e497. [PMID: 34323412 DOI: 10.1002/ctm2.497] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 22 |
Ye D, Deng Y, Shen Z. The Role and Mechanism of MALAT1 Long Non-Coding RNA in the Diagnosis and Treatment of Head and Neck Squamous Cell Carcinoma. Onco Targets Ther 2021;14:4127-36. [PMID: 34267526 DOI: 10.2147/OTT.S317234] [Reference Citation Analysis]
|
| 23 |
Ramaiah MJ, Kumar KR. mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme. Mol Biol Rep 2021;48:4813-35. [PMID: 34132942 DOI: 10.1007/s11033-021-06462-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 24 |
Qin J, Jiang C, Cai J, Meng X. Roles of Long Noncoding RNAs in Conferring Glioma Progression and Treatment. Front Oncol 2021;11:688027. [PMID: 34178684 DOI: 10.3389/fonc.2021.688027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Ghafouri-Fard S, Agabalazadeh A, Abak A, Shoorei H, Hassanzadeh Taheri MM, Taheri M, Sharifi G. Role of Long Non-Coding RNAs in Conferring Resistance in Tumors of the Nervous System. Front Oncol 2021;11:670917. [PMID: 34178658 DOI: 10.3389/fonc.2021.670917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 26 |
Cao Y, Chai W, Wang Y, Tang D, Shao D, Song H, Long J. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2. Mol Med Rep 2021;24:533. [PMID: 34036375 DOI: 10.3892/mmr.2021.12172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
DeSouza PA, Qu X, Chen H, Patel B, Maher CA, Kim AH. Long, Noncoding RNA Dysregulation in Glioblastoma. Cancers (Basel) 2021;13:1604. [PMID: 33807183 DOI: 10.3390/cancers13071604] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 28 |
Mahinfar P, Baradaran B, Davoudian S, Vahidian F, Cho WC, Mansoori B. Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma. Genes (Basel) 2021;12:455. [PMID: 33806782 DOI: 10.3390/genes12030455] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 29 |
Voce DJ, Bernal GM, Cahill KE, Wu L, Mansour N, Crawley CD, Campbell PS, Arina A, Weichselbaum RR, Yamini B. CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma. Sci Rep 2021;11:5665. [PMID: 33707466 DOI: 10.1038/s41598-021-84912-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Liu G, Liu B, Liu X, Xie L, He J, Zhang J, Dong R, Ma D, Dong K, Ye M. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3. J Cell Mol Med 2021;25:3524-36. [PMID: 33683826 DOI: 10.1111/jcmm.16435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 31 |
Zhao M, Shao Y, Xu J, Zhang B, Li C, Gong J. LINC00466 Impacts Cell Proliferation, Metastasis and Sensitivity to Temozolomide of Glioma by Sponging miR-137 to Regulate PPP1R14B Expression. Onco Targets Ther 2021;14:1147-59. [PMID: 33642868 DOI: 10.2147/OTT.S273264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 32 |
Rezaei O, Tamizkar KH, Sharifi G, Taheri M, Ghafouri-Fard S. Emerging Role of Long Non-Coding RNAs in the Pathobiology of Glioblastoma. Front Oncol 2020;10:625884. [PMID: 33634032 DOI: 10.3389/fonc.2020.625884] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 33 |
Li P, Jia Y, Tang W, Cui Q, Liu M, Jiang J. Roles of Non-coding RNAs in Central Nervous System Axon Regeneration. Front Neurosci 2021;15:630633. [PMID: 33597844 DOI: 10.3389/fnins.2021.630633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 34 |
Janaki Ramaiah M, Mohammad Naushad S, Reddy Manyam R, Kutala VK. Role of long noncoding RNAs in temozolomide-resistant glioblastoma. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 2021. [DOI: 10.1016/b978-0-12-821567-8.00001-4] [Reference Citation Analysis]
|
| 35 |
Bronisz A, Rooj AK, Krawczyński K, Peruzzi P, Salińska E, Nakano I, Purow B, Chiocca EA, Godlewski J. The nuclear DICER-circular RNA complex drives the deregulation of the glioblastoma cell microRNAome. Sci Adv 2020;6:eabc0221. [PMID: 33328224 DOI: 10.1126/sciadv.abc0221] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 36 |
Tian S, Tang M, Li J, Wang C, Liu W. Identification of long non-coding RNA signatures for squamous cell carcinomas and adenocarcinomas. Aging (Albany NY) 2020;13:2459-79. [PMID: 33318305 DOI: 10.18632/aging.202278] [Reference Citation Analysis]
|
| 37 |
Cai H, Yu Y, Ni X, Li C, Hu Y, Wang J, Chen F, Xi S, Chen Z. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis. Cell Death Dis 2020;11:1032. [PMID: 33268783 DOI: 10.1038/s41419-020-03247-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 38 |
Yu X, Zhang J, Yang R, Li C. Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks. Biomed Res Int 2020;2020:8579651. [PMID: 33299877 DOI: 10.1155/2020/8579651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 39 |
Stackhouse CT, Gillespie GY, Willey CD. Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential. Cells 2020;9:E2369. [PMID: 33126510 DOI: 10.3390/cells9112369] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 40 |
Zhu X, Bu F, Tan T, Luo Q, Zhu J, Lin K, Huang J, Luo C, Zhu Z. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer. J Exp Clin Cancer Res 2020;39:207. [PMID: 33023613 DOI: 10.1186/s13046-020-01717-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 41 |
Peng T, Wang T, Liu G, Zhou L. Effects of miR-373 Inhibition on Glioblastoma Growth by Reducing Limk1 In Vitro. J Immunol Res 2020;2020:7671502. [PMID: 33062725 DOI: 10.1155/2020/7671502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 42 |
Chen W, Li Q, Zhang G, Wang H, Zhu Z, Chen L. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis. J Cell Mol Med 2020;24:11755-67. [PMID: 32918360 DOI: 10.1111/jcmm.15788] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 43 |
Arun G, Aggarwal D, Spector DL. MALAT1 Long Non-Coding RNA: Functional Implications. Noncoding RNA 2020;6:E22. [PMID: 32503170 DOI: 10.3390/ncrna6020022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 16.7] [Reference Citation Analysis]
|
| 44 |
Xu H, Zhang B, Yang Y, Li Z, Zhao P, Wu W, Zhang H, Mao J. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis. J Cell Mol Med 2020;24:6362-72. [PMID: 32319715 DOI: 10.1111/jcmm.15280] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 45 |
Liang M, Hu K. Involvement of lncRNA-HOTTIP in the Repair of Ultraviolet Light-Induced DNA Damage in Spermatogenic Cells. Mol Cells 2019;42:794-803. [PMID: 31697875 DOI: 10.14348/molcells.2019.0121] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 46 |
Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, Chen L, Lyu X, Shi Z, Yan W, You Y. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer 2020;19:28. [PMID: 32039732 DOI: 10.1186/s12943-020-1137-5] [Cited by in Crossref: 82] [Cited by in F6Publishing: 94] [Article Influence: 27.3] [Reference Citation Analysis]
|
| 47 |
Liu Q, Qi C, Li G, Su W. Prediction of the Outcome for Patients with Glioblastoma with lncRNA Expression Profiles. Biomed Res Int 2019;2019:5076467. [PMID: 31950039 DOI: 10.1155/2019/5076467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 48 |
Cui RJ, Fan JL, Lin YC, Pan YJ, Liu C, Wan JH, Wang W, Jiang ZY, Zheng XL, Tang JB, Yu XG. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma. Cancer Med 2019;8:6358-69. [PMID: 31466138 DOI: 10.1002/cam4.2482] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
|
